3 ms·
If they’ve raised capital for a series of clinical trials, you can reasonably assume the doses at which they expect to see clinical effects are much higher than
by arkades 7y ago
If they’ve raised capital for a series of clinical trials, you can reasonably assume the doses at which they expect to see clinical effects are much higher than you’re likely to get just from food ingestion - otherwise their competition would just be pomegranate juice pills or something, sold as a food supplement and requiring no trials of safety or efficacy. They’d never have been able to raise a cent.
In other words, no one would fund a penicillin trial if they thought people could get by eating moldy bread from GNC.
- derefr 7y agoI don’t know. The dose of broccoli you need to see clinical effects from the sulforaphane it contains is extremely high, but concentrated sulforaphane capsules are sold as a food supplement without needing to go through any FDA process. What criterion does the FDA use to distinguish a food-derived chemical that needs to be treated as a drug, from one that’s still just seen as an extract/essence of the food itself, and therefore can be treated as a supplement? It seems very opaque to me.